Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS



Status:Archived
Conditions:Pneumonia, Infectious Disease, HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2009
End Date:March 2012

Use our guide to learn which trials are right for you!

A Phase 3, Open-label, Single-Arm Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 3 Doses of 13vPnC Vaccine in HIV-Infected Subjects 18 Years of Age or Older Who Have Been Previously Immunized With 23vPS Vaccine


The study will evaluate the safety, tolerability and immunogenicity of a 13-valent
pneumococcal conjugate vaccine (13vPnC) in HIV-infected subjects 18 years of age or older
who have been previously immunized with at least one dose of 23-valent pneumococcal
polysaccharide vaccine (23vPS). All subjects will receive 3 doses of 13vPnC, with each study
vaccine dose given approximately 6 months apart.



We found this trial at
9
sites
Los Angeles, California 90027
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
?
mi
from
Boston, MA
Click here to add this to my saved trials
Arvada, Colorado 80005
?
mi
from
Arvada, CO
Click here to add this to my saved trials
Ashland, Kentucky 41101
?
mi
from
Ashland, KY
Click here to add this to my saved trials
Bristol, Tennessee 37620
?
mi
from
Bristol, TN
Click here to add this to my saved trials
Burke, Virginia 22015
?
mi
from
Burke, VA
Click here to add this to my saved trials
Cape Girardeau, Missouri 63703
?
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
106 Noroton Ave
Darien, Connecticut 06820
(203) 655-9741
Darien Pediatric Associates Our office is pleased and privileged to care for your children and...
?
mi
from
Darien, CT
Click here to add this to my saved trials
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials